Fabio Malugani
- Co-authors
- Paolo LissoniGabriele TanciniFranco RovelliR BucovecMario MandalàG GardaniAntonio ArdizzoiaMassimo Vaghi
- Topics
- Circadian rhythm and melatonin (9 papers)Cancer Treatment and Pharmacology (5 papers)Angiogenesis and VEGF in Cancer (5 papers)
- Partner nations
- Italy
In The Last Decade
Fabio Malugani
28 papers receiving 883 citations
Peers
Comparison fields: 5 of 96
- Endocrine and Autonomic Systems 379
- Molecular Biology 286
- Oncology 227
- Immunology 126
- Physiology 111
Countries citing papers authored by Fabio Malugani
This map shows the geographic impact of Fabio Malugani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabio Malugani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabio Malugani more than expected).
Fields of papers citing papers by Fabio Malugani
This network shows the impact of papers produced by Fabio Malugani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabio Malugani. The network helps show where Fabio Malugani may publish in the future.
Co-authorship network of co-authors of Fabio Malugani
This figure shows the co-authorship network connecting the top 25 collaborators of Fabio Malugani. A scholar is included among the top collaborators of Fabio Malugani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabio Malugani. Fabio Malugani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | Biological response modifiers of cancer-related neuroendocrine disorders: efficacy of the long-term dopaminergic agonist cabergoline in the treatment of breast cancer-induced hyperprolactinemia. | 8 |
| 3 | Psychooncology and cancer progression-related alterations of pleasure-associated neurochemical system: Abnormal neuroendocrine response to apomorphine in advanced cancer patients. | 4 |
| 4 | 23 | |
| 5 | Reduction of cisplatin-induced anemia by the pineal indole 5-methoxytryptamine in metastatic lung cancer patients. | 12 |
| 6 | A phase II study of chemoneuroimmunotherapy with platinum, subcutaneous low-dose interleukin-2 and the pineal neurohormone melatonin (P.I.M.) as a second-line therapy in metastatic melanoma patients progressing on dacarbazine plus interferon-alpha. | 22 |
| 7 | Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1. | 88 |
| 8 | Ten-year survival results in metastatic renal cell cancer patients treated with monoimmunotherapy with subcutaneous low-dose interleukin-2. | 19 |
| 9 | Stimulation of IL-12 secretion by GM-CSF in advanced cancer patients. | 3 |
| 10 | A new neuroimmunotherapeutic strategy of subcutaneous low-dose interleukin-2 plus the long-acting opioid antagonist naltrexone in metastatic cancer patients progressing on interleukin-2 alone. | 16 |
| 11 | Effect of bicalutamide therapy on prolactin response to L-dopa in metastatic prostate cancer patients. | 72 |
| 12 | A clinical study of taxotere versus taxotere plus the antiprolactinemic agent bromocriptine in metastatic breast cancer pretreated with anthracyclines. | 19 |
| 13 | 16 | |
| 14 | Serum concentrations of interleukin-18 in early and advanced cancer patients: enhanced secretion in metastatic disease. | 33 |
| 15 | A study of light/dark rhythm of melatonin in relation to cortisol and prolactin secretion in schizophrenia. | 42 |
| 16 | Efficacy of bromocriptine in the treatment of metastatic breast cancer- and prostate cancer-related hyperprolactinemia. | 10 |
| 17 | 15 | |
| 18 | 208 | |
| 19 | 39 | |
| 20 | 3 |
About Fabio Malugani
Fabio Malugani is a scholar working on Endocrine and Autonomic Systems, Biological Psychiatry and Oncology, having authored 28 papers that have together received 941 indexed citations. Recurring topics across this work include Circadian rhythm and melatonin (9 papers), Cancer Treatment and Pharmacology (5 papers) and Angiogenesis and VEGF in Cancer (5 papers). The work is most often cited by research in Endocrine and Autonomic Systems (379 citations), Biological Psychiatry (60 citations) and Oncology (227 citations). Fabio Malugani has collaborated with scholars based in Italy. Frequent co-authors include Paolo Lissoni, Gabriele Tancini, Franco Rovelli, R Bucovec, Mario Mandalà, G Gardani, Antonio Ardizzoia, Massimo Vaghi, Ario Conti and Sandro Barni. Their work appears in journals such as Annals of Oncology, European Journal of Cancer and Journal of Pineal Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.